Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease.

ABSTRACT:

Background

Low socioeconomic status is associated with disadvantages in health outcomes and delivery of medical care in patients with Inflammatory Bowel Disease (IBD). Inequality in the utilisation of biologic treatment is largely unexplored.

Aim

To explore the potential association of socioeconomic status and time to first biologic treatment in a population-based IBD cohort.

Methods

All 37,380 IBD incidences between 2000 and 2017 from the Danish National Patient Register were identified and linked to socioeconomic information including educational level, income and occupational status at diagnosis. Hazard ratios for receiving biologic treatment among socioeconomic groups were estimated using Cox proportional hazard regression.

Results

No difference in time bet

SUBMITTER: Petersen SR 

PROVIDER: S-EPMC12370555 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature